The relationship between harming behavior and substance use profile, and attention deficit hyperactivity disorder symptoms in antisocial personality disorder
Onur Durmaz
Article No: 3   Article Type :  Research
Objective: The aim of this study was to investigate the relationship between substance use and harming behavior profile, and attention deficit hyperactivity disorder (ADHD) symptoms in young adult male population diagnosed with antisocial personality disorder (ASPD).

Method: The study enrolled 119 ASPD subjects who reported substance use history. All participants were administered sociodemographic data and clinical information form, Addiction Profile Index (API), and Adult ADD/ADHD DSM IV- Based Diagnostic Screening and Rating Scale (Adult ADHD Scale).

Results: The diagnosis subscale of API and hyperactivity/impulsivity subscale of Adult ADHD Scale scores were significantly higher in subjects with a history of suicide attempt. All subscales of Adult ADHD scale and all API subscales other than motivation subscale scores were significantly higher in forensic cases. In pairwise comparison, attention deficit, hyperactivity/impulsivity and total scores of Adult ADHD scale were significantly higher in moderate and high level addiction groups than low level addiction group. There was a significant correlation between all subscales of Adult ADHD scale and API except motivation subscale.

Conclusion: Our study suggests a considerable relationship between substance use profile and harming behavior, and ADHD symptoms in people with ASPD.
Keywords : Antisocial personality, attention deficit hyperactivity, harming behaviour, substance use
Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2017;30:194-201
1.Moran P. The epidemiology of antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol 1999; 34:231-242.

2.Glenn AL, Johnson AK, Raine A. Antisocial personality disorder: a current review. Curr Psychiatry Rep 2013; 15:427.

3.Ak I, Sayar S. Sociobiological factors in antisocial personality disorder. Bulletin of Clinical Psychopharmacology 2002; 12:155-158. (Turkish)

4.Alegria AA, Blanco C, Petry NM, Skodol AE, Liu SM, Grant B, Hasin D. Sex differences in antisocial personality disorder: results from the National Epidemiological Survey on Alcohol and Related Conditions. Personal Disord 2013; 4:214-222.

5.Smith RV, Young AM, Mullins UL, Havens JR. Individual and network correlates of antisocial personality disorder among rural nonmedical prescription opioid users. J Rural Health 2016; 33:198-207.

6.Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama 1990; 264:2511-2518.

7.Werner KB, Few LR, Bucholz KK. Epidemiology, comorbidity, and behavioral genetics of antisocial personality disorder and psychopathy. Psychiatr Ann 2015; 45:195-199.

8.Simsek S, Gokcen C, Fettahoglu EC. Attention deficit hyperactivity disorder (ADHD) and other psychiatric symptoms in parents of children with ADHD. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2012; 25:230-237.

9.Ekinci S, Oncu B, Canat S. Adult attention deficit hyperactivity disorder: comorbidity and functioning. Anadolu Psikiyatri Derg 2011; 12:185-191.

10.Harty SC, Miller CJ, Newcorn JH, Halperin JM. Adolescents with childhood ADHD and comorbid disruptive behavior disorders: aggression, anger, and hostility. Child Psychiatry Hum Dev 2009; 40:85-97.

11.Young S, Sedgwick O, Fridman M, Gudjonsson G, Hodgkins P, Lantigua M, Gonzalez RA. Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis. Psychol Med 2015; 45:2499-2510.

12.Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med 2009; 39:685-693.

13.Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, Castellanos FX. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012; 69:1295-1303.

14.Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH, Castellanos FX. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 2008; 165:604-609.

15.Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug Alcohol Depend 2013; 129:18-24.

16.Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003; 112:497-507.

17.Ogel K, Evren C, Karadag F, Gurol T. The development, validity, and reliability of the Addiction Profile Index (API). Turk Psikiyatri Derg 2012; 23:264-273.

18.Gunay S, Savran C, Aksoy UM. Linguistic equivalence, validity, reliability and norm study of Adult ADD/ADHD DSM IV-Based Diagnostic Screening and Rating Scale. Psychiatry in Turkey 2006; 8:98-107.(Turkish)

19.Ramos Olazagasti MA, Klein RG, Mannuzza S, Belsky ER, Hutchison JA, Lashua-Shriftman EC, Castellanos FX. Does childhood attention- deficit/hyperactivity disorder predict risk-taking and medical illnesses in adulthood? J Am Acad Child Adolesc Psychiatry 2013; 52:153-162.

20.Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit- hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry 2008; 42:405-413.

21.Bozkurt M, Evren C, Umut G, Evren B. Relationship of attention- deficit/hyperactivity disorder symptom severity with severity of alcohol-related problems in a sample of inpatients with alcohol use disorder. Neuropsychiatr Dis Treat 2016; 12:1661-1667.

22.Emmerik van Oortmerssen K, Glind G, Koeter MWJ, Allsop S, Auriacombe M, Barta C, Bu ETH, Burren Y, Carpentier PJ, Carruthers S. Psychiatric comorbidity in treatment seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014; 109:262-272.

23.Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV, Biederman J. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005; 14:319-327.

24.Tomko RL, Bountress KE, Gray KM. Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend 2016; 167:1-7.

25.Ortal S, van de Glind G, Johan F, Itai B, Nir Y, Iliyan I, van den Brink W. The role of different aspects of impulsivity as independent risk factors for substance use disorders in patients with adhd: a review. Curr Drug Abuse Rev 2014; 8:119- 133.

26.Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152:1652-1658.

27.Carpentier PJ, Van Gogh MT, Knapen LJM, Buitelaar JK, De Jong CAJ. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone- maintained patients. Eur Addict Res 2010; 17:10-20.

28.Sternat T, Katzman MA. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat 2016; 12:2149-2164.

29.Chambers RA, Taylor JR, Potenza MN. Developmental Neurocircuitry of Motivation in Adolescence: A Critical Period of Addiction Vulnerability. Am J Psychiatry 2003; 160:1041-1052.

30.Bácskai E, Czobor P, Gerevich J. Trait aggression, depression and suicidal behavior in drug dependent patients with and without ADHD symptoms. Psychiatry Res 2012; 200:719-723.
11th National Alcohol and Substance Abuse Congress
Creative Commons Lisansı

Dusunen Adam: The Journal of Psychiatry and Neurological Sciences is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi
Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi
Yerküre Tanıtım ve Yayıncılık Hizmetleri A.Ş.